International Patent: NATURAL KILLER CELLS EXPRESSING DUAL-TARGETING CHIMERIC ANTIGEN RECEPTORS FOR CD19 AND CD22, AND USES THEREOF

GENEVA, Aug. 31 -- UCI THERAPEUTICS INC. filed a patent application (KR2026/002907) for “NATURAL KILLER CELLS EXPRESSING DUAL-TARGETING CHIMERIC ANTIGEN RECEPTORS FOR CD19 AND CD22, AND USES THEREOF”. With publication no. WO/2026/177560, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/0783

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....